Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy (Q40587916)

21 September 2017

title

Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy (English)

1 reference

21 September 2017

1 reference

Chi-Feng Lee

1

1 reference

21 September 2017

Sun-Yran Chang

series ordinal

2

1 reference

21 September 2017

Dar-Shih Hsieh

series ordinal

3

1 reference

21 September 2017

Dah-Shyong Yu

series ordinal

4

1 reference

21 September 2017

publication date

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

11

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

194-207

1 reference

Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Mycobacterial cell wall extract for treatment of carcinoma in situ of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Dissecting the immunobiological effects of Bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Interleukin-12. Opportunities for the treatment of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

BCG immunotherapy of bladder cancer: 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Immunotherapy of murine bladder cancer by irradiated tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Genetically modified tumour vaccines--where we are today.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

The regulation of DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Enhanced secretion and uptake of beta-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

21 January 2018

Regulators of cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Bcl-2 and the regulation of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Cell death in granulomata: the role of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

Complications of bacillus Calmette-Guerin therapy in superficial urothelial cancer: clinical analysis and implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

Bacillus Calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

Intravesical instillations of interferon gamma in the prophylaxis of high risk superficial bladder cancer--results of a controlled prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

Corticotropin-releasing factor produces a protein synthesis--dependent long-lasting potentiation in dentate gyrus neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

In vivo electrically mediated protein and gene transfer in murine melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

The induction of bacillus-Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700658

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700658

1 reference

Dimensions Publication ID

21 September 2017

1017273528

0 references

1 reference